Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

NCT00492505 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: cisplatin
DRUG: sorafenib tosylate
DRUG: tamoxifen citrate
PROCEDURE: adjuvant therapy

Sponsor

San Diego Pacific Oncology & Hematology Associates